Research in Novel Immune Adjuvants
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Immunology".
Deadline for manuscript submissions: 30 March 2025 | Viewed by 33
Special Issue Editor
Special Issue Information
Dear Colleagues,
Despite essential improvements being made in vaccine immunogenicity, adjuvants are always studied with an awkward lag compared to vaccine discovery. Over a long period of time, a very limited number of adjuvants have been clinically approved, all of which are associated with aluminum salts, monophosphoryl lipid A, and oil emulsions. However, increasing evidence has demonstrated that adjuvants alter the quantity and quality of adaptive immune responses through activating innate immunity. Those immune responses differ by population and may have distinct safety risks. Recent innovations in adjuvant research have intersected with formulation science, immunology, toxicology, biology, etc. More importantly, human in vitro models, immuno-engineering, and novel delivery systems are being proposed to identify biomarkers of safety and adjuvanticity. Immunological adjuvants exploited through adopting novel multidisciplinary approaches therefore hold promise to become precision adjuvants, optimizing science and safety.
Dr. Bei Li
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- adjuvants
- vaccine
- immunology
- toxicology
- biology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
